Clinical Trials - VYGR

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT05490225Access Cannulation Trial IIRECRUITINGNA2025-04-232027-03-252027-03-25
NCT06874621VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's DiseaseRECRUITINGPHASE1, PHASE22025-03-032027-052027-05
NCT04885114Safety and Tolerability Study With VY-HTT01, in Adults With Early Manifesting Huntington's DiseaseWITHDRAWNPHASE12021-07-302024-12-302024-12-30